J&J Innovation Talks CNS Partnering And Alzheimer's Challenges
J&J Innovation's senior director of neuroscience innovation, Prof. John Isaac, talks to Scrip on the sidelines of the BIO-Europe Spring partnering meeting in Amsterdam about the unmet needs in neurology and the partnering approach J&J Innovation has for the development of new therapeutics for devastating neurodegenerative conditions such as Alzheimer's disease.
You may also be interested in...
Infographic: Top 100 Pharma Companies
The Scrip 100 universe gathers FY2021 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.
Snapshot: April Highlights
A selection of articles you might have missed from April 2022, including exclusive interviews, an in depth look at the impact of COVID-19 on clinical trial trends, and the latest Rising Leaders series.
Transforming Patient Engagement At Novartis
Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action.